Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
340
Trial Sponsor
Clinical Trial Start Date
June 3, 2021
0Primary Completion Date
September 16, 2021
0Study Completion Date
September 29, 2021
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Other0
Intervention Type
Drug0
Intervention Name
SPR2060
Interventional Trial Phase
Phase 10
Official Name
A Phase 1, Single-Center, Open-Label Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 by Comparing the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations Following the Intravenous Administration of SPR206 in Healthy Volunteers0
Last Updated
November 17, 2021
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
To evaluate the intrapulmonary pharmacokinetics (PK), including epithelial lining fluid (ELF) and alveolar macrophage (AM) concentrations, of SPR206 as well as plasma concentrations of SPR206 in healthy adult volunteers.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
